FDA Inspection 1080590 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on Dec 14, 2018 in Jining. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jining (China)